Drug Chatter -- Tracking biopharma stock chatter

Profile for Alexza Pharmaceuticals, Inc. (ALXA)

« Back to company index

ALXA Chatter Timeline

Stock Ticker for ALXA

Most Active Tweeters for ALXA

UserTweets
@ZolmaxNews 1
@AmericanBanking 1
@ConsumerFeed 1

Recent Tweets for ALXA

ZolmaxNews @ZolmaxNews
$ALXA, $RGRX - Head-To-Head Review: Alexza Pharmaceuticals #ALXA and RegeneRx… https://t.co/e6Pr6xHQTR
December 7th 2017, 11:12pm
AmericanBanking @AmericanBanking
Financial Survey: Alexza Pharmaceuticals $ALXA vs. Endo International $ENDP https://t.co/52wjZgjWn4
December 4th 2017, 5:12pm
ConsumerFeed @ConsumerFeed
Financial Survey: Alexza Pharmaceuticals $ALXA vs. Endo International $ENDP https://t.co/W4fd5bfT3G #acn
December 4th 2017, 5:12pm
SleekMoneycom @SleekMoneycom
Alexza Pharmaceuticals $ALXA Earning Somewhat Negative Media Coverage, Study Shows https://t.co/U21DhEToQt
October 24th 2017, 7:10pm
specstockscom @specstockscom
Get your say in on $ALXA at SpeculatingStocks, the discovery engine. No login required! #stocks https://t.co/Y8rPX0XdGz
October 17th 2017, 9:10am
stocknewstimes @stocknewstimes
Alexza Pharmaceuticals $ALXA Receiving Somewhat Critical News Coverage, Accern Reports https://t.co/ylQV3mLqwL
October 15th 2017, 7:10pm
TickerReport @TickerReport
Alexza Pharmaceuticals $ALXA Receiving Somewhat Critical News Coverage, Accern Reports https://t.co/NSplvqe5OT
October 15th 2017, 7:10pm
thelegacynewswi @thelegacynewswi
Alexza Pharmaceuticals $ALXA Receiving Somewhat Critical News Coverage, Accern Reports https://t.co/tYoj6O8IgA #stocks
October 15th 2017, 7:10pm
emq_news @emq_news
Alexza Pharmaceuticals $ALXA Receiving Somewhat Critical News Coverage, Accern Reports https://t.co/rEwRT7afba
October 15th 2017, 7:10pm
TickerReport @TickerReport
Alexza Pharmaceuticals $ALXA Receiving Somewhat Critical News Coverage, Accern Reports https://t.co/dq5gKqYGvz
October 15th 2017, 7:10pm
SleekMoneycom @SleekMoneycom
Alexza Pharmaceuticals $ALXA Receiving Somewhat Critical News Coverage, Accern Reports https://t.co/U21DhEToQt
October 15th 2017, 7:10pm
ZolmaxNews @ZolmaxNews
Alexza Pharmaceuticals $ALXA Receiving Somewhat Negative News Coverage, Analysis Finds https://t.co/N9iZblsnYt
October 3rd 2017, 5:10pm
TheMarketsDaily @TheMarketsDaily
Alexza Pharmaceuticals $ALXA Receives Daily Coverage Optimism Rating of -0.04 https://t.co/UbjR66finH
September 27th 2017, 5:09pm
SleekMoneycom @SleekMoneycom
Somewhat Positive Press Coverage Somewhat Unlikely to Impact Alexza Pharmaceuticals $ALXA Stock Price https://t.co/HltGmOAaLt
September 24th 2017, 9:09am
chaffeybreeze @chaffeybreeze
Alexza Pharmaceuticals $ALXA Earns Daily Coverage Optimism Rating of 0.06 https://t.co/7pVfUqC5OR
September 21st 2017, 6:09pm
IRAMarketReport @IRAMarketReport
Alexza Pharmaceuticals $ALXA Earns Daily Coverage Optimism Rating of 0.06 https://t.co/8twpWiVLtX
September 21st 2017, 6:09pm
SleekMoneycom @SleekMoneycom
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Alexza Pharmaceuticals $ALXA Share Price https://t.co/HltGmOAaLt
September 16th 2017, 5:09pm
stocknewstimes @stocknewstimes
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Alexza Pharmaceuticals $ALXA Share Price https://t.co/JdGzLpoWvg
September 16th 2017, 5:09pm
TickerReport @TickerReport
Alexza Pharmaceuticals $ALXA Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/10WJLkc5FA
September 15th 2017, 5:09pm
WeekHerald @WeekHerald
Alexza Pharmaceuticals $ALXA Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/EBOh8CzxPb
September 15th 2017, 5:09pm
TickerReport @TickerReport
Alexza Pharmaceuticals $ALXA Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/bbG2Cy8T7U
September 15th 2017, 5:09pm
emq_news @emq_news
Alexza Pharmaceuticals $ALXA Getting Somewhat Favorable Media Coverage, Study Shows https://t.co/VrVJYmUmlK
September 15th 2017, 5:09pm
offshorehunters @offshorehunters
$ALXA nice one in chat early today https://t.co/bB7K4kPKAy https://t.co/hoYHBPcJRy
September 14th 2017, 4:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.